Atlas Trials

Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT06952231 · COMPLETED

Trial details

NCT number
NCT06952231
Sponsor
University of Lahore
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2024-05-21
Primary completion
2024-12-10
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.